Published in Stem Cells on August 30, 2007
Oxygen tension regulates pancreatic beta-cell differentiation through hypoxia-inducible factor 1alpha. Diabetes (2009) 1.19
Embryonic mouse blood flow and oxygen correlate with early pancreatic differentiation. Dev Biol (2010) 1.17
Current status of islet cell transplantation. J Hepatobiliary Pancreat Surg (2008) 1.07
Enhanced expression of VEGF-A in β cells increases endothelial cell number but impairs islet morphogenesis and β cell proliferation. Dev Biol (2012) 1.01
FEM-based oxygen consumption and cell viability models for avascular pancreatic islets. Theor Biol Med Model (2009) 0.97
Commercially available gas-permeable cell culture bags may not prevent anoxia in cultured or shipped islets. Transplant Proc (2008) 0.91
Prevention of autoimmune diabetes and induction of β-cell proliferation in NOD mice by hyperbaric oxygen therapy. Diabetes (2012) 0.90
Renal blood flow and oxygenation drive nephron progenitor differentiation. Am J Physiol Renal Physiol (2014) 0.87
High oxygen condition facilitates the differentiation of mouse and human pluripotent stem cells into pancreatic progenitors and insulin-producing cells. J Biol Chem (2014) 0.84
New insights into endocrine pancreatic development: the role of environmental factors. Horm Res Paediatr (2010) 0.83
HIF1α and pancreatic β-cell development. FASEB J (2012) 0.82
Submersion and hypoxia inhibit ciliated cell differentiation in a notch-dependent manner. Am J Respir Cell Mol Biol (2014) 0.82
Activation of the transcription factor carbohydrate-responsive element-binding protein by glucose leads to increased pancreatic beta cell differentiation in rats. Diabetologia (2012) 0.81
Addition of perfluorocarbons to alginate hydrogels significantly impacts molecular transport and fracture stress. J Biomed Mater Res A (2012) 0.81
Microencapsulated 3-dimensional sensor for the measurement of oxygen in single isolated pancreatic islets. PLoS One (2012) 0.79
A synopsis of factors regulating beta cell development and beta cell mass. Cell Mol Life Sci (2016) 0.75
Influence of in vitro and in vivo oxygen modulation on β cell differentiation from human embryonic stem cells. Stem Cells Transl Med (2013) 0.75
Ionic regulation of proliferation of NIE-115 mouse neuroblastoma cells in vitro. Dokl Biochem Biophys (2009) 0.75
International trial of the Edmonton protocol for islet transplantation. N Engl J Med (2006) 13.43
The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci U S A (2006) 5.41
Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature (2005) 3.62
Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell (2005) 3.52
Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med (2011) 3.19
Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant (2005) 3.07
Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA (2012) 2.85
A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations. Am J Transplant (2005) 2.74
Innervation patterns of autonomic axons in the human endocrine pancreas. Cell Metab (2011) 2.48
Noninvasive in vivo imaging of pancreatic islet cell biology. Nat Med (2008) 2.41
Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Diabetes (2010) 2.36
Rescue purification maximizes the use of human islet preparations for transplantation. Am J Transplant (2005) 2.04
Glutamate is a positive autocrine signal for glucagon release. Cell Metab (2008) 2.01
Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets. Hepatology (2011) 1.94
The use of exenatide in islet transplant recipients with chronic allograft dysfunction: safety, efficacy, and metabolic effects. Transplantation (2008) 1.83
Stopping type 1 diabetes: attempts to prevent or cure type 1 diabetes in man. Diabetes (2011) 1.77
Long-term insulin independence and improvement in insulin secretion after supplemental islet infusion under exenatide and etanercept. Transplantation (2008) 1.66
Alpha cells secrete acetylcholine as a non-neuronal paracrine signal priming beta cell function in humans. Nat Med (2011) 1.62
Quantitative differential expression analysis reveals miR-7 as major islet microRNA. Biochem Biophys Res Commun (2007) 1.54
Edmonton's islet success has indeed been replicated elsewhere. Lancet (2003) 1.45
Regulation of alloimmune responses (GvH reactions) in vitro by autologous donor bone marrow cell preparation used in clinical organ transplantation. Transplantation (2002) 1.42
Discussion: "On the Thermodynamical Admissibility of the Triphasic Theory of Charged Hydrated Tissues" (Huyghe, J. M., Wilson, W., and Malakpoor, K., ASME J. Biomech. Eng., 2009, 131, p. 044504). J Biomech Eng (2009) 1.39
ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors. Sci Signal (2011) 1.38
Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device. Transplantation (2006) 1.37
ATP-gated P2X3 receptors constitute a positive autocrine signal for insulin release in the human pancreatic beta cell. Proc Natl Acad Sci U S A (2010) 1.35
Endocrine cell clustering during human pancreas development. J Histochem Cytochem (2009) 1.26
Toward maximizing the success rates of human islet isolation: influence of donor and isolation factors. Cell Transplant (2007) 1.26
Rapamycin impairs in vivo proliferation of islet beta-cells. Transplantation (2007) 1.26
Retinoic acid promotes the generation of pancreatic endocrine progenitor cells and their further differentiation into beta-cells. PLoS One (2008) 1.24
MicroRNA miR-7 is preferentially expressed in endocrine cells of the developing and adult human pancreas. Gene Expr Patterns (2008) 1.24
Preventing hypoxia-induced cell death in beta cells and islets via hydrolytically activated, oxygen-generating biomaterials. Proc Natl Acad Sci U S A (2012) 1.23
Aptamer-mediated blockade of IL4Rα triggers apoptosis of MDSCs and limits tumor progression. Cancer Res (2012) 1.22
High-resolution, noninvasive longitudinal live imaging of immune responses. Proc Natl Acad Sci U S A (2011) 1.22
Transthyretin constitutes a functional component in pancreatic beta-cell stimulus-secretion coupling. Proc Natl Acad Sci U S A (2005) 1.22
Point: steady progress and current challenges in clinical islet transplantation. Diabetes Care (2009) 1.20
Combined treatment of intrapancreatic autologous bone marrow stem cells and hyperbaric oxygen in type 2 diabetes mellitus. Cell Transplant (2008) 1.17
The use of the BD oxygen biosensor system to assess isolated human islets of langerhans: oxygen consumption as a potential measure of islet potency. Cell Transplant (2006) 1.13
Regional differences in islet distribution in the human pancreas--preferential beta-cell loss in the head region in patients with type 2 diabetes. PLoS One (2013) 1.13
Assessment of cytotoxic lymphocyte gene expression in the peripheral blood of human islet allograft recipients: elevation precedes clinical evidence of rejection. Diabetes (2004) 1.13
Interference with tissue factor prolongs intrahepatic islet allograft survival in a nonhuman primate marginal mass model. Transplantation (2007) 1.13
Allosensitization of islet allograft recipients. Transplantation (2007) 1.13
Pure mucinous carcinoma of the breast: is axillary staging necessary? Ann Surg Oncol (2002) 1.12
Requirements for success in clinical islet transplantation. Transplantation (2005) 1.11
Transplantation: current developments and future directions; the future of clinical islet transplantation as a cure for diabetes. Front Biosci (2008) 1.11
Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients. Transplantation (2002) 1.11
Hepatocyte growth factor enhances engraftment and function of nonhuman primate islets. Diabetes (2008) 1.09
Human fibrocytic myeloid-derived suppressor cells express IDO and promote tolerance via Treg-cell expansion. Eur J Immunol (2014) 1.08
Prediction of clinical outcome in islet allotransplantation. Diabetes Care (2007) 1.08
Human, nonhuman primate, and rat pancreatic islets express erythropoietin receptors. Transplantation (2003) 1.08
MicroRNA expression in alpha and beta cells of human pancreatic islets. PLoS One (2013) 1.08
Current status of islet cell transplantation. J Hepatobiliary Pancreat Surg (2008) 1.07
Cell replacement strategies aimed at reconstitution of the β-cell compartment in type 1 diabetes. Diabetes (2014) 1.07
Concise review: mesenchymal stem cells for diabetes. Stem Cells Transl Med (2011) 1.06
Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center. Transplantation (2002) 1.06
Donor islet endothelial cells in pancreatic islet revascularization. Diabetes (2011) 1.05
Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody. Transplantation (2003) 1.05
Restoration of hypoglycemia awareness after islet transplantation. Diabetes Care (2008) 1.04
Overcoming the challenges now limiting islet transplantation: a sequential, integrated approach. Ann N Y Acad Sci (2006) 1.04
Concise review: clinical programs of stem cell therapies for liver and pancreas. Stem Cells (2013) 1.03
Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation. Transplantation (2008) 1.03
A new nonenzymatic method and device to obtain a fat tissue derivative highly enriched in pericyte-like elements by mild mechanical forces from human lipoaspirates. Cell Transplant (2012) 1.03
Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction. Cell Transplant (2009) 1.03
Biliary tree stem cells, precursors to pancreatic committed progenitors: evidence for possible life-long pancreatic organogenesis. Stem Cells (2013) 1.02
CD40-CD40 ligand interaction activates proinflammatory pathways in pancreatic islets. Diabetes (2006) 1.02
Automated, high-throughput assays for evaluation of human pancreatic islet function. Cell Transplant (2008) 1.02
The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation. Am J Transplant (2005) 1.01
Adipocyte transplantation and stem cells: plastic surgery meets regenerative medicine. Cell Transplant (2010) 1.00
Islet allograft survival in nonhuman primates immunosuppressed with basiliximab, RAD, and FTY720. Transplantation (2004) 1.00
Improved long-term health-related quality of life after islet transplantation. Transplantation (2008) 1.00
Prescription checking device promises to resolve intractable hypoglycemia. J Diabetes Sci Technol (2009) 1.00
Financial incentives for cadaver organ donation: an ethical reappraisal. Transplantation (2002) 1.00
Beta-cell transplantation for diabetes therapy. Lancet (2008) 0.99
The role of mitochondrial nitric oxide synthase in inflammation and septic shock. Free Radic Biol Med (2002) 0.99
Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice. Diabetes (2003) 0.99
Minimization and withdrawal of steroids in pancreas and islet transplantation. Transpl Int (2008) 0.99
Immunosuppression and procedure-related complications in 26 patients with type 1 diabetes mellitus receiving allogeneic islet cell transplantation. Transplantation (2005) 0.99
Cell and organ bioengineering technology as applied to gastrointestinal diseases. Gut (2012) 0.98
Procurement of the human pancreas for pancreatic islet transplantation. Transplantation (2004) 0.98
Effect of the purinergic inhibitor oxidized ATP in a model of islet allograft rejection. Diabetes (2013) 0.97
Macroporous three-dimensional PDMS scaffolds for extrahepatic islet transplantation. Cell Transplant (2012) 0.97
Islet transplantation with alemtuzumab induction and calcineurin-free maintenance immunosuppression results in improved short- and long-term outcomes. Transplantation (2008) 0.97
Dapsone-induced artifactual a1c reduction in islet transplant recipients. Transplantation (2007) 0.97
The oxidative stress and the mitochondrial dysfunction caused by endotoxemia are prevented by alpha-lipoic acid. Free Radic Res (2008) 0.96